Development of a New Therapeutic Approach to B Cell Malignancy. The Induction of Immunity by the Host Against Cell Surface Receptor on the Tumor
- 1 January 1989
- journal article
- review article
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 4 (4), 251-270
- https://doi.org/10.3109/08830188909044782
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Somatic Mutation in Human B‐Cell TumorsImmunological Reviews, 1987
- Syngeneic antiidiotypic immune responses to a B cell lymphoma. Comparison between heavy chain hypervariable region peptides and intact Ig as immunogens.The Journal of Experimental Medicine, 1985
- Emergence of Idiotype Variants during Treatment of B-Cell Lymphoma with Anti-Idiotype AntibodiesNew England Journal of Medicine, 1985
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyNew England Journal of Medicine, 1982
- Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfacesBritish Journal of Cancer, 1980
- Tumor Immunity Induced by Preimmunization With BALB/c Mouse Myeloma Protein2JNCI Journal of the National Cancer Institute, 1976
- Antibodies to idiotypes of isologous immunoglobulins.The Journal of Experimental Medicine, 1975
- Myeloma Proteins as Tumor-Specific Transplantation AntigensProceedings of the National Academy of Sciences, 1972
- Autoimmune-Like Antibodies to the Ligand-Binding Sites of Myeloma ProteinsProceedings of the National Academy of Sciences, 1971
- CONTRIBUTION TO THE KNOWLEDGE OF SARCOMAAnnals of Surgery, 1891